Marcin Kolaczynski Email & Phone Number

Lucerne, Switzerland

Lausanne Area, Switzerland

Globally responsible for developing the medical strategy and the evidence development plan for business projects with a health benefit focus.• Analyzed the gaps and devised the Standard Operating Procedure (SOP) on the appoval of market sponsored studies for the business. Conducted the SOP training to the business• Designed, wrote study protocol for the validation of the new non-invasive device and supervised the execution of the study registered at clinicaltrial.gov.• Prepared and organized a scientific session at the global corporate scientific meeting.• Created and launched the database for the most influential scientific Key Opinion Leaders for the Top 10 Markets. • Coordinated creation of the scientific dossier for successful regulatory approval and launch of new product.• Served as scientific and medical expert providing input to seven global product dossiers.

Basel Area, Switzerland

Responsible for Global Medical Affairs activities for launched products.• Designed and launched Field Medical Excellence (MSL) Portal to provide uniform medical training for field based medical advisors worldwide.• Initiated and led joint Medical Affairs (GMA) and Medical Information (GMI) quarterly communications.• Led and innovated the Medical Affairs Study Team (MAST) process improving the quality of phase 4 study proposals (process implemented in franchise and globally).• Supported Global Publication Plan and introduced global support to Regions and CPOs. • Created, consulted and approved scientific communications, medical and promotional materials within the Global Materials Clearing Committee.

London, United Kingdom

Responsible for the EU Research & Development activities for the new in class product.• Represented EU Clinical Science and Development Team for decisions within the global strategy.• Led the EU R&D activities relating to the preparation/ approval of synopses, protocols and conduct of clinical studies (8 CDP studies) for a compound (TAK-875) in the new drug class. • Supported and assessed data for Product Safety and Regulatory departments to ensure timely approval of the product labelling.• Responsible for medical due diligence evaluations for potential business development or in-licensing opportunities.

Poland

National Board member responsible for National Medical Affairs activities for launched and new products. Managed the Medical Affairs team of 8 professionals.• Built structure, recruited, trained and managed the Medical Affairs team.• Defined and led direction for national medico-marketing strategy.• Launched with the MSL team new product.• Improved sales force effectiveness devising training on product and medical knowledge- yearly certification of Commercial/ Field Sales Department (+ 80 sales representatives).• Led National Advisory Board and designed Medical Experts engagement plan; successfully built international links for national Medical Experts.• Directed and approved Medical Communications and Publication Plan.

Switzerland

Responsible for regional medical affairs activities for launched and new products. • Chaired and led the EU Medical Affairs Board defining regional medical strategy.• Served as the EU representative at the Global Medical Scientific Team for core products.• Supervised medical support to the EU launch of the new product.• Coordinated design and implementation of the European Medical Science Liaison (MSL) Model.• Designed, launched ‘Medical Advisor/ MSL Portal’.• Created and launched the ‘Key Medical Expert (KME) Directory’.• Managed and budgeted regional clinical activities.• Devised approval process for Phase 4 studies, wrote protocol templates.• Managed Regional publication plan.

Denmark

Responsible for Global Medical Affairs activities for launched and new products. • Strategized and managed marketing strategy for company’s first blockbuster product and liaised with other MA for strategic alignment for the brands.• Devised and created the medico-scientific educational portal.• Coordinated Medical Affairs activities in all regional offices as the key medical contact for global medical inquiries.• Planned, presented, and executed medical activities/ events with Key Medical Experts during international congresses, meetings and advisory boards. • Led and coordinated Global Medical Publication Team, Medical Communications and Medical Information activities.• Prepared medical input for regulatory dossiers.• Provided input and approved study protocols for CDP, wrote protocols for Phase 4 studies.• Awarded ‘Best Pre-Launch Activity Award’ for commercial launch of the new device -2005.

Denmark

Responsible for medical and scientific coverage and support to International/ Global Marketing.• Devised and led medico-marketing activities (Global Publication and Medical Information plans) for products within global Diabetes Strategy & Insulin Portfolio Lifecycle Management Plan (4 product groups).• Developed uniform medical dossiers and integrated publication plan for products portfolio. • Aligned medical activities across + 10 top markets with global medico-marketing strategies.• Managed relationships with worldwide medical thought leaders (Ad-boards, speaker trainings).

Poland

Managed national marketing team. Responsible for strategy, tactical plans and product launches.• Planned and executed national medico- marketing strategy (9 products).• Devised new targeting and segmentation model- global sharing practise- Global Award 2001.• Designed and led ‘Diabetes Children Education Project’- Global Award 2000.• Launched 3 new products exceeding sales targets while managing 3 product managers.

Poland

Responsible for medical and scientific training for the Sales Force.• Designed the first medico- scientific training for sales representatives- trained 25+ trainees